NIH SBIR/STTR Funding Readiness & Strategic Assessment

Make a clearer funding decision before you start writing.

Is your innovation ready for an NIH SBIR or STTR application?

The answer depends on more than whether your science is promising. Your company’s eligibility, research evidence, proposed milestones, commercialization strategy, and ability to execute all matter when deciding whether—and how—to pursue funding.

Blue Haven Grant Consultants helps life science innovators evaluate their position, identify questions that need to be resolved, and build an application strategy aligned with their research and business goals.

Whether you are preparing your first application, translating university research into a company, or considering the next stage of development, start with a clearer understanding of your funding path.

Are you eligible—or are you ready?

Eligibility and readiness are different questions.

Eligibility concerns whether your company and proposed project meet the program’s formal requirements. NIH SBIR and STTR applications must come from eligible U.S. small businesses. A university may participate as a research partner, but it does not apply as the small-business applicant.

Readiness is the strategic question: Can you make a persuasive, well-supported case for the work you want NIH to fund?

Our readiness framework helps you consider both.

1. Company and collaboration structure

   Is the applicant appropriately structured, and are the company’s responsibilities and research partnerships clear?

2. Scientific foundation

   What evidence supports the concept, and what important uncertainties remain?

3. Research plan

   Can the next stage of work be expressed through clear aims, measurable milestones, and an executable approach?

4. Commercial direction

   Who would use or benefit from the innovation, and what would need to happen for it to reach that market?

5. Team and resources

   Do you have access to the expertise, facilities, collaborators, and operational support the project requires?

6. Funding fit and timing

   Does the proposed opportunity match the work you need to do and the time available to prepare?

   This framework is a planning tool—not an NIH scoring system or a prediction of an award.

Who this is for?

Life science founders preparing a first application

You have a promising technology and need to understand whether NIH small-business funding fits your next development milestone.

University researchers and spinout teams

You are exploring how academic research could move into a company-led development program and need to clarify the applicant structure, partnerships, and responsibilities.

Biotech and medical device companies

You need to connect a technically credible research plan with the practical steps required to advance a product.

Teams with existing feasibility evidence

You have already completed meaningful development work and want to assess whether Phase I, Fast-Track, or an available Direct to Phase II opportunity deserves consideration.

Which NIH funding pathway fits your project?

The right starting point depends on what your project has already demonstrated and what the next stage of research needs to accomplish.

Phase I-Establishing feasibility, technical merit, and commercial potential (What do we still need to demonstrate before committing to a larger development program?)

Fast-Track-Combining Phase I and Phase II work in one application (Can we define a credible feasibility stage and a sufficiently developed follow-on plan?)

Direct to Phase II-Advancing eligible projects with demonstrated feasibility without a prior Phase I award for that project (Does our existing evidence support moving directly into the proposed Phase II work?)

These pathways are not interchangeable. Availability and requirements depend on the specific funding opportunity and participating NIH institute or center. Direct to Phase II is an SBIR pathway; it should not be assumed to be available through STTR.

Choosing a pathway should begin with your evidence and development needs—not simply the size of the potential award.

SBIR or STTR: Does your research partnership change the decision?

Both programs support small-business research and development, but their collaboration structures differ.

SBIR permits research partnerships. STTR requires a formal partnership with a nonprofit research institution, such as a university. The programs also have different work-allocation and principal-investigator employment requirements.

For university-connected teams, that makes the relationship between the company and the research institution an early planning decision—not a detail to resolve after the proposal is written.

Before moving forward, consider:

• Which organization will perform each part of the research?

• Where will the principal investigator be employed?

• Are the necessary facilities, expertise, and research resources available?

• Have intellectual-property and institutional obligations been identified for review?

• Does the proposed structure fit the requirements of the selected opportunity?

A clear collaboration plan helps your team evaluate the appropriate program and identify questions that need institutional, legal, or other specialist review.

How Blue Haven helps you move from an idea to an application strategy

Our approach begins with understanding your innovation and the business behind it. We connect project evaluation, scientific strategy, and proposal development so that the application reflects the work your company needs to accomplish.

1. Understand the project and the decision ahead

We begin with your technology, the problem it addresses, your development progress, and the goals you want funding to support.

The first question is not simply, “Can we write an application?”

It is, “What funding strategy makes sense for this project?”

2. Clarify the scientific case

We work to make the proposed problem, innovation, and research objectives clear.

Our Significance-Innovation Analysis™ helps articulate the problem your solution addresses, how your approach differs from existing alternatives, and why the proposed work matters.

The objective is to build a focused scientific narrative—not simply describe an interesting technology.

3. Identify gaps before they become proposal problems

Together, we examine questions that could weaken the application strategy, including:

• Aims that are too broad or insufficiently connected.

• Assumptions that need stronger supporting evidence.

• Missing expertise or collaborator commitments.

• A research scope that does not fit the proposed resources.

• A mismatch between the development stage and funding pathway.

• An unclear connection between the research and commercial opportunity.

The goal is to identify what needs attention before your team commits substantial effort to drafting.

4. Build a coordinated proposal plan

When the project is ready to move forward, we help connect scientific content, Specific Aims, supporting documents, and the broader business strategy into a coherent application process.

Rather than treating each section as a separate writing assignment, we work toward an application whose components support the same research and development story.

What if your project is not ready yet?

A useful assessment should do more than encourage an application.

It should help your team distinguish among three practical next steps.

Move toward proposal development

Your project, supporting evidence, and opportunity fit are sufficiently clear to begin developing the application.

Resolve targeted gaps first

Your project may benefit from additional evidence, collaborator commitments, clearer milestones, or a more focused research scope before drafting begins.

Reconsider the pathway or timing

A different funding approach or submission timeframe may better fit your company’s development needs.

“Not yet” can still be a productive outcome—if you leave knowing what needs to change.

Grant strategy that fits your business

Funding is one part of building a successful company.

Your research priorities, development milestones, available resources, and broader financing strategy should inform the application—not sit apart from it.

Blue Haven combines scientific and business expertise to help clients develop a grant strategy that fits their operational goals. Our work is tailored to the company rather than built around a one-size-fits-all application process.

Ask about BHGC Pay Upon Award™

Blue Haven offers its BHGC Pay Upon Award™ pricing model, which ties payment to a successful award rather than requiring payment for an unsuccessful application.

Discuss the model, covered services, and applicable engagement terms with our team.

A payment model is not a guarantee of funding. The decision to pursue an application should still begin with project fit and a clear understanding of the work ahead.

Frequently asked questions

Do I need a finished product before pursuing NIH SBIR/STTR funding?

No. These programs support research and development. Phase I focuses on feasibility, technical merit, and commercial potential, while later pathways support further development. The evidence you need depends on the pathway and proposed work.

Can a university researcher apply?

The applicant must be an eligible small business, not the university itself. University researchers may participate through an appropriately structured company and research collaboration. STTR specifically requires a nonprofit research-institution partner.

Do we have to complete Phase I first?

Not always. NIH offers pathways that can include Fast-Track and, where available and appropriate, SBIR Direct to Phase II. Direct to Phase II requires demonstrated feasibility; it is not simply a shortcut around missing evidence.

Does meeting the eligibility requirements mean we have a competitive application?

No. Eligibility establishes whether your company and project meet formal program requirements. Readiness considers additional strategic questions: the research rationale, supporting evidence, proposed work, team, and development direction.

Can Blue Haven help if we have not started writing?

Yes. Early project evaluation and strategic planning can help clarify the scientific case, identify gaps, and establish a more focused direction before proposal development begins.

What should we prepare for an initial conversation?

A useful starting point is:

• A short, nonconfidential description of the technology.

• The problem it is intended to solve.

• A summary of development progress and available evidence.

• The next research milestone you want to reach.

• An overview of the company and research team.

• Any funding opportunity or submission timeframe you are considering.

You do not need a polished proposal to begin the conversation. Avoid submitting confidential technical information through an initial inquiry form.

Find your next step toward NIH funding

Before investing in an application, get clearer on the project you want to fund, the evidence you have, and the pathway worth evaluating.

Talk with Blue Haven about your innovation, your current stage of development, and the questions standing between your team and a focused application strategy.